OBJECTIVE
Existing patient-reported outcome (PRO) measures for systemic sclerosis (SSc) have important limitations, including inadequate coverage of early disease and limited inclusion of diffuse cutaneous (dcSSc) and limited cutaneous (lcSSc) subtypes. This paper reports on the development of two PRO measures for earl...
George J. Greene, C. Perschon, Emilie Jaeger et al.· Arthritis care & research· 0 citations
How PROs are used in MS clinical care is determined and insights into instruments, purposes, facilitators/barriers, and impact are gained to gain insights into instruments, purposes, facilitators/barriers, and impact.
M. Kuharić, C. Nowinski, C. Perschon et al.· Multiple Sclerosis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.